NCT02146599

Brief Summary

The purpose of this study is to evaluate the visual quality and function of pseudophakic patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
301

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2014

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

May 20, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 26, 2014

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

September 7, 2015

Completed
Last Updated

September 28, 2015

Status Verified

September 1, 2015

Enrollment Period

2 months

First QC Date

May 20, 2014

Results QC Date

July 7, 2015

Last Update Submit

September 10, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Use of Corrective Visual Aids (i.e., Spectacles, Contact Lenses) Post Intraocular Lens (IOL) Surgery

    Patients will be assessed at a baseline visit and a visit 1 week later to determine their use of corrective visual aids (i.e., spectacles, contact lenses) post Intraocular Lens (IOL) surgery.

    Baseline and 1 week

Study Arms (1)

Pseudophakic

Other: Administration of patient self-assessment

Interventions

Eligibility Criteria

Age22 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Bilaterally-implanted pseudophakic subjects over 22 years of age who meet the inclusion criteria.

You may qualify if:

  • Minimum 22 years of age
  • Pseudophakic patients who have been bilaterally implanted with the same type of intraocular lenses in both eyes
  • Ability to understand, read and write English to give consent and complete the study questionnaires
  • Availability, willingness, and sufficient cognitive awareness to comply with examination procedures and study visits
  • Signed informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization

You may not qualify if:

  • Any ocular pathology of clinical significance, as determined by the investigator, that may affect visual outcomes or influence subjective ocular/visual symptoms
  • Patient is pregnant or is lactating
  • Concurrent participation or participation within 30 days prior in any other clinical trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Daniel Chang, M.D.

Bakersfield, California, 93309, United States

Location

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Results Point of Contact

Title
Anne Buteyn; Manager, Clinical Research
Organization
Abbott Medical Optics

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 20, 2014

First Posted

May 26, 2014

Study Start

May 1, 2014

Primary Completion

July 1, 2014

Study Completion

July 1, 2014

Last Updated

September 28, 2015

Results First Posted

September 7, 2015

Record last verified: 2015-09

Locations